This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cai, D. Articles by Lerner, A. Search for Related Content PubMed PubMed Citation Articles by Cai, D. Articles by Lerner, A.

AND-34/BCAR3, a GDP Exchange Factor Whose Overexpression Confers Antiestrogen Resistance, Activates Rac, PAK1, and the Cyclin D1 Promoter¹

Department of Medicine, Sections of Hematology and Oncology [R. I. N., A. L.] and Endocrinology [Z. L.], Boston Medical Center and Department of Pathology, Boston University School of Medicine [D. C., A. I., K. N. F., A. L.], Boston, Massachusetts 02118; The Fox Chase Cancer Center, Philadelphia, Pennsylvania 19100 [J. C.]; and Department of Oncology, Lombardi Cancer Center, Georgetown University, Washington, D.C. 20007 [C. A., R. G. P.]

AND-34 is a murine protein that binds by a cdc25-like GDP exchange factor domain to the focal adhesion docking protein p130Cas. Overexpression of either of the human homologues of AND-34 and p130Cas, BCAR3 and BCAR1, respectively, has been reported to induce resistance to antiestrogens in breast cancer cell lines. Here we show that overexpression of AND-34 leads to activation of the Rho family GTPases Cdc42 and Rac. Consistent with these findings, BCAR3 overexpression induced alterations in F-actin distribution and augmented both autophosphorylation and kinase activity of the Cdc42/Rac-responsive serine/threonine kinase PAK1. p130Cas-associated BCAR3 protein was detected in the estrogen-independent breast cancer cell line 578-T, but not in estrogen-dependent MCF7 or ZR-75-1 cells. Stable ZR-75-1 transfectants overexpressing BCAR3, but not vector-only transfectants, grew in the presence of the pure antiestrogen ICI 182,780. Stable transfection with RacV12, a constitutively active form of Rac1, also induced antiestrogen resistance in ZR-75-1 cells. Transient transfection of BCAR3 in estrogen-dependent MCF7 cells induced activation of luciferase constructs containing the proximal 1745 or 163 bp but not 66 bp of the cyclin D1 promoter. Such cyclin D1 promoter activation was inhibited by dominant negative forms of Rac1 and PAK1. Overexpression of the PAK1 autoinhibitory domain (residues 83–149) but not an inactive PAK1 autoinhibitory domain point mutant (L107F) also blocked BCAR3-mediated cyclin D1 activation. These studies suggest that AND-34/BCAR3 induces antiestrogen resistance in breast cancer cell lines by a Rac1- and PAK1-dependent pathway.

This article has been cited by other articles:

				V. P. Kovacheva, J. M. Davison, T. J. Mellott, A. E. Rogers, S. Yang, M. J. O'Brien, and J. K. Blusztajn Raising gestational choline intake alters gene expression in DMBA-evoked mammary tumors and prolongs survival FASEB J, April 1, 2009; 23(4): 1054 - 1063. [Abstract] [Full Text] [PDF]

				R. S. Schrecengost, R. B. Riggins, K. S. Thomas, M. S. Guerrero, and A. H. Bouton Breast Cancer Antiestrogen Resistance-3 Expression Regulates Breast Cancer Cell Migration through Promotion of p130Cas Membrane Localization and Membrane Ruffling Cancer Res., July 1, 2007; 67(13): 6174 - 6182. [Abstract] [Full Text] [PDF]

				A. L. Zarling, J. M. Polefrone, A. M. Evans, L. M. Mikesh, J. Shabanowitz, S. T. Lewis, V. H. Engelhard, and D. F. Hunt From the Cover: Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy PNAS, October 3, 2006; 103(40): 14889 - 14894. [Abstract] [Full Text] [PDF]

				S. K. Rayala, P. R. Molli, and R. Kumar Nuclear p21-Activated Kinase 1 in Breast Cancer Packs Off Tamoxifen Sensitivity. Cancer Res., June 15, 2006; 66(12): 5985 - 5988. [Abstract] [Full Text] [PDF]

				V. A. Rufanova and A. Sorokin CrkII Associates with BCAR3 in Response to Endothelin-1 in Human Glomerular Mesangial Cells Exp Biol Med, June 1, 2006; 231(6): 752 - 756. [Abstract] [Full Text] [PDF]

				S. K. Rayala, A. H. Talukder, S. Balasenthil, R. Tharakan, C. J. Barnes, R.-A. Wang, M. Aldaz, S. Khan, and R. Kumar P21-Activated Kinase 1 Regulation of Estrogen Receptor-{alpha} Activation Involves Serine 305 Activation Linked with Serine 118 Phosphorylation Cancer Res., February 1, 2006; 66(3): 1694 - 1701. [Abstract] [Full Text] [PDF]

				K. N. Felekkis, R. P. Narsimhan, R. Near, A. F. Castro, Y. Zheng, L. A. Quilliam, and A. Lerner AND-34 Activates Phosphatidylinositol 3-Kinase and Induces Anti-Estrogen Resistance in a SH2 and GDP Exchange Factor-Like Domain-Dependent Manner Mol. Cancer Res., January 1, 2005; 3(1): 32 - 41. [Abstract] [Full Text] [PDF]

				M. Dail, M. S. Kalo, J. A. Seddon, J.-F. Cote, K. Vuori, and E. B. Pasquale SHEP1 Function in Cell Migration Is Impaired by a Single Amino Acid Mutation That Disrupts Association with the Scaffolding Protein Cas but Not with Ras GTPases J. Biol. Chem., October 1, 2004; 279(40): 41892 - 41902. [Abstract] [Full Text] [PDF]